annb0t
Top 20
Recce Pharmaceuticals
SYDNEY, Australia, July 13, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it received further non-dilutive funds from Radium Capital (Radium) for A$801,604 of Recceâs future R&D tax incentive.
âWe welcome the latest R&D rebate advance of A$801,604 to support our ongoing clinical progress and achieve our operational goals,â said Ja...
>>> Read more: Recce Pharmaceuticals Receives A$801,604 Research and Development (R&D) Rebate Advance
SYDNEY, Australia, July 13, 2023 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it received further non-dilutive funds from Radium Capital (Radium) for A$801,604 of Recceâs future R&D tax incentive.
âWe welcome the latest R&D rebate advance of A$801,604 to support our ongoing clinical progress and achieve our operational goals,â said Ja...
>>> Read more: Recce Pharmaceuticals Receives A$801,604 Research and Development (R&D) Rebate Advance
